About Dr. Wang Qun
Dr. Wang Qun (王群) is one of China's most distinguished thoracic surgeons and the Director of the Department of Thoracic Surgery at Zhongshan Hospital, affiliated with Fudan University. He holds the title of Chief Physician and Professor and is nationally recognized as a leading authority on minimally invasive thoracic surgery, lung cancer surgery, and esophageal cancer surgery.
Over a career spanning more than three decades, Dr. Wang has established Zhongshan Hospital's Thoracic Surgery Department as one of the highest-volume and most technically advanced thoracic surgery centers in China. He is particularly renowned for his expertise in video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery (RATS) for lung cancer — areas where his technical innovations and high-volume experience have placed Zhongshan Hospital among the top thoracic surgery centers in Asia.
International patients with lung cancer, esophageal cancer, mediastinal tumors, or other thoracic conditions consistently identify Dr. Wang as one of China's top thoracic surgeons for both primary surgical treatment and expert second opinions.
Professional Positions and Affiliations
- Director, Department of Thoracic Surgery, Zhongshan Hospital, Fudan University
- Chairman, Chinese Society for Thoracic and Cardiovascular Surgery (Thoracic Section)
- Vice Chairman, Chinese Society of Thoracic Oncology
- Editorial Board Member: Journal of Thoracic and Cardiovascular Surgery (JTCVS), European Journal of Cardio-Thoracic Surgery (EJCTS), Annals of Thoracic Surgery
- Fellow, American Association for Thoracic Surgery (AATS)
- Fellow, European Association for Cardio-Thoracic Surgery (EACTS)
Specialties and Clinical Expertise
- Lung Cancer Surgery — VATS and robotic lobectomy, segmentectomy, and pneumonectomy; sublobar resection for ground-glass opacity (GGO) nodules; sleeve resection for central tumors; lymph node dissection; one of China's highest-volume VATS lung cancer surgeons
- Esophageal Cancer Surgery — minimally invasive esophagectomy (MIE) by thoracoscopic and robotic approaches; Ivor Lewis, McKeown, and transhiatal esophagectomy; gastric conduit and colon interposition reconstruction
- Mediastinal Tumors — thymoma and thymic carcinoma resection (VATS and robotic); mediastinal germ cell tumors; neurogenic tumors; mediastinal cysts
- Pleural Disease — malignant pleural mesothelioma; pleural effusion management; VATS pleurodesis and decortication
- Tracheal Surgery — tracheal resection and reconstruction for tracheal tumors and stenosis
- Pulmonary Nodule Management — CT-guided localization and VATS resection of small pulmonary nodules; GGO surveillance and surgical timing
- Neoadjuvant and Adjuvant Therapy Coordination — surgical planning after neoadjuvant immunotherapy or chemotherapy for locally advanced lung and esophageal cancer
Academic and Research Contributions
Dr. Wang Qun has published over 200 peer-reviewed papers in leading international thoracic surgery journals, with a particular focus on VATS and robotic lung cancer surgery outcomes, minimally invasive esophagectomy, and the surgical management of pulmonary nodules. His landmark series on robotic lobectomy outcomes — one of the largest in Asia — has been widely cited and has contributed to the global adoption of robotic thoracic surgery. He is a regular invited speaker at AATS, EACTS, and the International Association for the Study of Lung Cancer (IASLC) World Conference.
Why International Patients Choose Dr. Wang Qun
- China's leading minimally invasive thoracic surgeon — Chairman of China's national thoracic surgery society
- Highest-volume VATS and robotic lung cancer surgery center in eastern China
- Esophageal cancer surgery expertise — minimally invasive esophagectomy with low complication rates
- AATS and EACTS Fellow — internationally credentialed and aligned with global thoracic surgery standards
- Pulmonary nodule expertise — GGO management and sublobar resection for early lung cancer
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Zhongshan Hospital, 180 Fenglin Road, Xuhui District, Shanghai
- Appointment Lead Time: 2″4 weeks; urgent cases expedited through CMCS
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Pre-consultation: Overseas CT, PET-CT, bronchoscopy, and pathology reports reviewed remotely through CMCS
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking thoracic surgery with Dr. Wang Qun at Zhongshan Hospital. Our services include priority appointment booking, medical record and imaging translation, remote pre-consultation review, on-site interpretation, accommodation coordination, insurance liaison, and post-surgical follow-up with your home country oncologist or pulmonologist.
📧 Contact us: contract@medicalsh.com
💬 WeChat: gezhanglao
🌐 medicalsh.com
0 Kommentare